CompletedPhase 2NCT02324751

Vaccines Against Salmonella Typhi

Studying Typhoid

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Oxford
Principal Investigator: Andrew J Pollard, FRCPCH, PhD, LMFT, LPCC
Oxford Vaccine Group, The University of Oxford
Intervention: Vi-TCV(biological)
Enrollment: 112 target
Eligibility: 18-60 years · All sexes
Timeline: 2015 – 2022

Study locations (1)

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02324751 on ClinicalTrials.gov

Other trials for Typhoid

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950
Induction of Gut Permeability by an Oral Vaccine
USDA, Western Human Nutrition Research Center
ACTIVE NOT RECRUITINGPHASE3NCT03299426
Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
University of Maryland, Baltimore
ACTIVE NOT RECRUITINGPHASE4NCT03970304
CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults
University of Maryland, Baltimore

See all trials for Typhoid →

← Back to all trials